Ysios Capital’s portfolio company CVRx Inc. prices IPO on NASDAQ

Desinversión, Venture Capital

05/07/2021 Press release YSIOS CAPITAL´S PORTFOLIO COMPANY CVRX INC. PRICES IPO ON NASDAQ. − CVRx, Inc. (Minneapolis, US) is a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases. It’s main product, Barostim NEO, a novel product for treatment of heart failure, was…

Columbus Venture Partners completa el primer cierre de su fondo Columbus Life Science Fund II con un objetivo de €70M

Fundraising, Venture Capital

04/02/2019 Nota de prensa COLUMBUS VENTURE PARTNERS COMPLETA EL PRIMER CIERRE DE SU FONDO COLUMBUS LIFE SCIENCE FUND II CON UN OBJETIVO DE €70 MILLONES. Columbus Venture Partners a leading biotechnology venture capital firm in Spain, today announced the registration at the CNMV of its second fund Columbus Life Science Fund II, FCR with a…